Drug Shortage Report for OCTREOTIDE ACETATE OMEGA
Report ID | 129156 |
Drug Identification Number | 02248640 |
Brand name | OCTREOTIDE ACETATE OMEGA |
Common or Proper name | Octreotide Acetate Injection |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | OCTREOTIDE |
Strength(s) | 100MCG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS |
Packaging size | 5 x 1mL vial / fiole |
ATC code | H01CB |
ATC description | HYPOTHALAMIC HORMONES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-10-29 |
Estimated end date | Unknown |
Actual end date | 2021-02-09 |
Shortage status | Resolved |
Updated date | 2021-02-10 |
Company comments | On allocation. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-02-10 | French | Compare |
v3 | 2021-02-10 | English | Compare |
v2 | 2020-11-30 | French | Compare |
v1 | 2020-11-30 | English | Compare |
Showing 1 to 4 of 4